Recent News
€17m fine imposed to pharma pirate Leadiant upheld on appeal
AMSTERDAM, THE NETHERLANDS: The District Court of Rotterdam has rejected the appeal of pharmaceutical company Leadiant against the 2021 decision of the Netherlands Competition Authority...
Human Rights/Global health researcher
Vacancy: Human rights/global health researcherThe Pharmaceutical Accountability Foundation is looking for a motivated part-time researcher to develop the methodology for a Fair Pharma Cancer Scorecard....
The Lancet on the PAF AbbVie case: AbbVie to face potentially groundbreaking case over Humira
The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to the...
PRESS RELEASE: Lawsuit against AbbVie for abuse of economic dominance and violation of human rights moves to substantive phase
AbbVie's Humira pricing policy drained up to €1.2 billion from the Dutch healthcare system
AMSTERDAM, NETHERLANDS: Today the Amsterdam District Court ruled that the lawsuit filed...
The Pharmaceutical Accountability Foundation faces AbbVie in Court for the first time in its Humira pricing case
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had abused...
“Six billion people have access to medicines today. So a lot has been achieved”
Wilbert Bannenberg, Chair of the Pharmaceutical Accountability Foundation, was interviewed by the Volkskrant on his life's work: promoting global equitable access to medicines. The article...